These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27620973)

  • 21. Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort.
    Turk WJ; Kimani J; Bielawny T; Wachihi C; Ball TB; Plummer FA; Luo M
    AIDS; 2013 Jan; 27(1):7-15. PubMed ID: 23032415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada.
    Keynan Y; Becker M; Rueda Z; Bresler K; Kasper K
    Infect Dis (Lond); 2015 Jul; 47(7):447-52. PubMed ID: 25746818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
    Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
    Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population.
    Katoh J; Kawana-Tachikawa A; Shimizu A; Zhu D; Han C; Nakamura H; Koga M; Kikuchi T; Adachi E; Koibuchi T; Gao GF; Brumme ZL; Iwamoto A
    PLoS One; 2016; 11(3):e0150397. PubMed ID: 26953793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection.
    MacDonald KS; Fowke KR; Kimani J; Dunand VA; Nagelkerke NJ; Ball TB; Oyugi J; Njagi E; Gaur LK; Brunham RC; Wade J; Luscher MA; Krausa P; Rowland-Jones S; Ngugi E; Bwayo JJ; Plummer FA
    J Infect Dis; 2000 May; 181(5):1581-9. PubMed ID: 10823757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression.
    Grifoni A; Montesano C; Palma P; Salerno A; Colizzi V; Amicosante M
    Mol Immunol; 2013 Apr; 53(4):410-3. PubMed ID: 23103378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.
    Thomas R; Apps R; Qi Y; Gao X; Male V; O'hUigin C; O'Connor G; Ge D; Fellay J; Martin JN; Margolick J; Goedert JJ; Buchbinder S; Kirk GD; Martin MP; Telenti A; Deeks SG; Walker BD; Goldstein D; McVicar DW; Moffett A; Carrington M
    Nat Genet; 2009 Dec; 41(12):1290-4. PubMed ID: 19935663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection.
    Hardie RA; Luo M; Bruneau B; Knight E; Nagelkerke NJ; Kimani J; Wachihi C; Ngugi EN; Plummer FA
    AIDS; 2008 Apr; 22(7):807-16. PubMed ID: 18427198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comment on "Influence of HLA-C expression level on HIV control".
    Lo Monaco E; Tremante E; Biswas P; Cranage MP; Zipeto D; Beretta A; Giacomini P
    Science; 2013 Sep; 341(6151):1175. PubMed ID: 24031002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression.
    Freguja R; Gianesin K; Zanchetta M; De Rossi A
    New Microbiol; 2012 Jul; 35(3):249-57. PubMed ID: 22842595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.
    Oxenius A; Price DA; Hersberger M; Schlaepfer E; Weber R; Weber M; Kundig TM; Böni J; Joller H; Phillips RE; Flepp M; Opravil M; Speck RF;
    J Infect Dis; 2004 Apr; 189(7):1199-208. PubMed ID: 15031788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive host immune adaptation in a concentrated North American HIV epidemic.
    Brumme ZL; Kinloch NN; Sanche S; Wong A; Martin E; Cobarrubias KD; Sandstrom P; Levett PN; Harrigan PR; Joy JB
    AIDS; 2018 Sep; 32(14):1927-1938. PubMed ID: 30048246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenetic basis of HIV-1 infection, transmission and disease progression.
    Singh P; Kaur G; Sharma G; Mehra NK
    Vaccine; 2008 Jun; 26(24):2966-80. PubMed ID: 18321617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
    Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to Comment on "Influence of HLA-C expression level on HIV control".
    Apps R; Carrington M
    Science; 2013 Sep; 341(6151):1175. PubMed ID: 24031003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to HIV infection.
    Marmor M; Hertzmark K; Thomas SM; Halkitis PN; Vogler M
    J Urban Health; 2006 Jan; 83(1):5-17. PubMed ID: 16736351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between KIR genotypes and HLA-B alleles on viral load in Southern Brazilian individuals infected by HIV-1 subtypes B and C.
    Fernandes-Cardoso J; Süffert TA; Correa MDG; Jobim LFJ; Jobim M; Salim PH; Arruda MB; Boullosa LT; Tanuri A; Porto LC; Ferreira OC
    Hum Immunol; 2016 Oct; 77(10):854-860. PubMed ID: 27346697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
    Saina MC; Bi X; Lihana R; Lwembe R; Ishizaki A; Panikulam A; Palakudy T; Musoke R; Owens M; Songok EM; Ichimura H
    PLoS One; 2015; 10(8):e0137140. PubMed ID: 26317223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.